The role of butyrate in surgical and oncological outcomes in colorectal cancer

Butyrate is a short-chain fatty acid produced by colonic gut bacteria as a result of fermentation of dietary fibers. In the colon, butyrate is a major energy substrate and contributes to the nutritional support and proliferation of a healthy mucosa. It also promotes the intestinal barrier function by enhancing mucus production and tight junctions. In addition to its pro-proliferative effect in healthy colonocytes, butyrate inhibits the proliferation of cancer cells. The antineoplastic effect of butyrate is associated with the inhibitory effect of butyrate on histone deacetylase (HDAC) enzymes, which promote carcinogenesis. Due to the metabolic shift of cancer cells toward glycolysis, unused butyrate accumulates and inhibits procarcinogenic HDACs. In addition, recent studies suggest that butyrate may improve the healing of colonic tissue after surgery in animal models, specifically at the site of reconnection of colonic ends, anastomosis, after surgical resection. Here, we review current evidence on the impact of butyrate on epithelial integrity and colorectal cancer and present current knowledge on data that support its potential applications in surgical practice.

Automated summary

Butyrate, a short-chain fatty acid produced by colonic gut bacteria through dietary fiber fermentation, acts as a major energy substrate in the colon and supports the proliferation of healthy mucosa while inhibiting cancer cell growth. Its antineoplastic effect is linked to its inhibition of histone deacetylase (HDAC) enzymes, which promote carcinogenesis, and it may also aid in the healing of colonic tissue post-surgery.